Thus, T1D-protective IL2 allelic variants impinge the development of γ-islet autoimmunity by bolstering the IL-2 production of pathogenic CD4+ Teff cells, and in turn, driving the functional homeostasis of CD4+Foxp3+ Treg cells in the target organ. The gene discussed is IL2; the disease is type 1 diabetes mellitus.